UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000034051
Receipt number R000031138
Scientific Title A study on the clinical usefulness of tissue oxygenation monitoring with OX Imager for peripheral arterial occlusive disease (PAD)
Date of disclosure of the study information 2018/09/06
Last modified on 2019/03/28 10:37:27

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title


A study on the clinical usefulness of tissue oxygenation monitoring with OX Imager for peripheral arterial occlusive disease (PAD)

Acronym


A study on the clinical usefulness of tissue oxygenation monitoring with OX Imager for peripheral arterial occlusive disease (PAD)

Scientific Title


A study on the clinical usefulness of tissue oxygenation monitoring with OX Imager for peripheral arterial occlusive disease (PAD)

Scientific Title:Acronym


A study on the clinical usefulness of tissue oxygenation monitoring with OX Imager for peripheral arterial occlusive disease (PAD)

Region

Japan


Condition

Condition

peripheral arterial disease

Classification by specialty

Vascular surgery

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Conventionally, the non-invasive blood flow evaluation method of limb arterial disease such as obstructive arteriosclerosis or Buerger disease is used as a gold standard for ankle-ankle artery pressure ratio (ABI), and in recent years it has been reported that skin perfusion pressure (SPP) and percutaneous oxygen partial pressure (TcPO 2) have also been clinically applied. However, these tests were time consuming and painful in some cases. OX Imager (manufactured by modulated Imaging, USA) can measure oxygen metabolism information of oxygen saturation, oxygenated hemoglobin concentration, deoxygenated hemoglobin concentration inside living tissue quantitatively and as an image without contacting the living body It is a possible device.
We will evaluate the blood flow of the ischemic limb using this device and consider the correlation with the conventional method ABI and the comparison with the conventional method with TcPO 2 and SPP.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

q

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Self control

Stratification

NO

Dynamic allocation

NO

Institution consideration

Institution is not considered as adjustment factor.

Blocking

NO

Concealment

No need to know


Intervention

No. of arms

1

Purpose of intervention

Diagnosis

Type of intervention

Device,equipment

Interventions/Control_1

Shoot foot with OX Imager. Record the values of blood oxygen saturation (StO 2), oxyhemoglobin (HbO 2), deoxyhemoglobin (HbR) of tissues obtained by photographing. The inspection time is about 30 seconds. The patient has no adverse effect at all.

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <

Age-upper limit

80 years-old >

Gender

Male and Female

Key inclusion criteria

Persons who aged 20 or over and under 80 are aged acquisition days.
Person who consented to participate in this research in document
Healthy volunteers
Patients with peripheral artery disease

Key exclusion criteria

Persons who may have pregnancy and pregnancy
Person who the researcher judged inappropriate
People who can not obtain consent to participate in this research

Target sample size

100


Research contact person

Name of lead principal investigator

1st name Naoki
Middle name
Last name Unno

Organization

Hamamatsu University School of Medicne

Division name

Second Deparment of Surgery

Zip code

431-3192

Address

1-20-1,Handayama,Higashi-ku,Hamamatsu city,Shizuoka prefecture,Japan

TEL

0534352111

Email

d16007@hama-med.ac.jp


Public contact

Name of contact person

1st name Takafumi
Middle name
Last name Kayama

Organization

Hamamatsu University School of Medicne

Division name

Second Deparment of Surgery

Zip code

431-3192

Address

1-20-1,Handayama,Higashi-ku,Hamamatsu city,Shizuoka prefecture,Japan

TEL

0534352111

Homepage URL


Email

d16007@hama-med.ac.jp


Sponsor or person

Institute

Hamamatsu University School of Medicne

Second Deparment of Surgery

Institute

Department

Personal name



Funding Source

Organization

Hamamatsu University School of Medicne

Second Deparment of Surgery

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Clinical Research Review Board of Hamamatsu University School of Medicine

Address

1-20-1,Handayama,Higashi-ku,Hamamatsu city,Shizuoka prefecture,Japan

Tel

0534352111

Email

kenkyou.s@hama-med.ac.jp


Secondary IDs

Secondary IDs

YES

Study ID_1

17-006

Org. issuing International ID_1

Hamamatsu University School of Medicine Ethics Committee

Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

浜松医科大学 第二外科


Other administrative information

Date of disclosure of the study information

2018 Year 09 Month 06 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2017 Year 04 Month 01 Day

Date of IRB

2017 Year 04 Month 04 Day

Anticipated trial start date

2017 Year 04 Month 04 Day

Last follow-up date

2022 Year 03 Month 31 Day

Date of closure to data entry

2022 Year 03 Month 31 Day

Date trial data considered complete


Date analysis concluded

2019 Year 03 Month 31 Day


Other

Other related information



Management information

Registered date

2018 Year 09 Month 06 Day

Last modified on

2019 Year 03 Month 28 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000031138


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name